Kimberly Stegmaier received the St. Baldrick’s Foundation Robert J. Arceci Innovation Award. Stegmaier is the vice chair of pediatric oncology research at the Dana-Farber Cancer Institute and co-director, Pediatric Hematologic Malignancy Program at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center.
The Biden administration has left NIH in a weakened state, intensifying politicization of science on Capitol Hill and eroding the bipartisan support the government’s premier biomedical research agency has traditionally enjoyed.
